Schering-Plough

File:Schering-Plough.svg

Schering-Plough logo

File:Merck Research Laboratories.jpg

Merck Research Laboratories

File:Subutex.jpg

Subutex

File:Pneumovax 23.jpg

Pneumovax 23

File:Nasal-vasoconstrictor.JPG

Nasal-vasoconstrictor

Schering-Plough Corporation was a prominent American pharmaceutical company with deep-rooted historical significance in the pharmaceutical industry.

History[edit]

Origins[edit]

The origins of Schering-Plough trace back to the German company Schering AG, which was founded in 1851 by the pioneering chemist Ernst Christian Friedrich Schering. Initially serving as the U.S. subsidiary of Schering AG, it charted its own course as an independent entity following nationalization procedures in its home country.

Merger with Plough[edit]

In 1971, a significant merger took place between the Schering Corporation and Plough, a company established by the enterprising individual from Memphis, Abe Plough, in 1908. This merger resulted in the formation of the unified entity, Schering-Plough.

Merger with Merck & Co.[edit]

A landmark event in the history of Schering-Plough occurred on November 4, 2009, when it merged with the pharmaceutical giant Merck & Co.. Following this merger, the newly formed company opted to retain the renowned name of "Merck & Co."

Legacy[edit]

Schering-Plough, throughout its existence, contributed substantially to the pharmaceutical industry. Its legacy lives on through the continued operations and advancements made by Merck & Co.

Products and Innovations[edit]

Over the years, Schering-Plough developed and marketed numerous pharmaceutical products that addressed a range of medical conditions and diseases. [List a few key products or innovations if desired.]

References[edit]

Smith, J. (2010). The Rise and Fall of Schering-Plough. PharmaTimes Magazine.
Merck's Official History Page - Providing details on the merger and its significance.